Simplex Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-38,598
Closed -$117K 4372
2024
Q4
$117K Buy
38,598
+14,220
+58% +$43.1K ﹤0.01% 1127
2024
Q3
$126K Sell
24,378
-33,744
-58% -$174K ﹤0.01% 1028
2024
Q2
$149K Buy
+58,122
New +$149K ﹤0.01% 1005
2024
Q1
Hold
0
4335
2023
Q4
Sell
-18,980
Closed -$217K 4368
2023
Q3
$217K Buy
18,980
+2,615
+16% +$29.9K ﹤0.01% 774
2023
Q2
$414K Buy
16,365
+784
+5% +$19.8K ﹤0.01% 618
2023
Q1
$501K Buy
15,581
+2,260
+17% +$72.7K ﹤0.01% 516
2022
Q4
$245K Sell
13,321
-34,280
-72% -$630K ﹤0.01% 722
2022
Q3
$1.29M Buy
47,601
+31,375
+193% +$847K ﹤0.01% 290
2022
Q2
$224K Sell
16,226
-11,628
-42% -$161K ﹤0.01% 818
2022
Q1
$543K Buy
+27,854
New +$543K ﹤0.01% 712
2021
Q4
Hold
0
4505
2021
Q3
Hold
0
3948
2021
Q2
Sell
-3,047
Closed -$85K 4116
2021
Q1
$85K Sell
3,047
-3,545
-54% -$98.9K ﹤0.01% 1498
2020
Q4
$186K Sell
6,592
-1,098
-14% -$31K ﹤0.01% 1040
2020
Q3
$193K Buy
+7,690
New +$193K ﹤0.01% 859
2020
Q2
Hold
0
3303
2020
Q1
Sell
-8,814
Closed -$143K 3267
2019
Q4
$143K Buy
8,814
+5,302
+151% +$86K ﹤0.01% 858
2019
Q3
$45K Sell
3,512
-71
-2% -$910 ﹤0.01% 1123
2019
Q2
$46K Buy
+3,583
New +$46K ﹤0.01% 1075
2019
Q1
Hold
0
3093
2018
Q4
Sell
-1,897
Closed -$47K 3073
2018
Q3
$47K Sell
1,897
-154
-8% -$3.82K ﹤0.01% 1284
2018
Q2
$56K Sell
2,051
-276
-12% -$7.54K ﹤0.01% 1213
2018
Q1
$71K Buy
+2,327
New +$71K ﹤0.01% 1008
2017
Q4
Sell
-4,559
Closed -$125K 2969
2017
Q3
$125K Sell
4,559
-1,127
-20% -$30.9K 0.01% 782
2017
Q2
$150K Sell
5,686
-1,865
-25% -$49.2K 0.01% 746
2017
Q1
$157K Buy
+7,551
New +$157K 0.01% 789
2016
Q4
Hold
0
2881
2016
Q3
Sell
-694
Closed -$9K 2857
2016
Q2
$9K Buy
+694
New +$9K ﹤0.01% 1320
2016
Q1
Sell
-17,365
Closed -$593K 2774
2015
Q4
$593K Buy
17,365
+8,300
+92% +$283K 0.05% 206
2015
Q3
$269K Buy
+9,065
New +$269K 0.02% 381
2015
Q2
Hold
0
2705